RAFAEL HOLDINGS, INC. Stockholders' Equity Attributable to Noncontrolling Interest
RAFAEL HOLDINGS, INC. (RFL) had Stockholders' Equity Attributable to Noncontrolling Interest of $5.42 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-06-11
- 2026-04-30: Stockholders' Equity Attributable to Noncontrolling Interest $5.42M.
- 2026-01-31: Stockholders' Equity Attributable to Noncontrolling Interest $4.09M.
- 2025-10-31: Stockholders' Equity Attributable to Noncontrolling Interest $4.00M.
- 2025-07-31: Stockholders' Equity Attributable to Noncontrolling Interest $3.98M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest | Stockholders' Equity Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-04-30 | $5.42M 10-Q · filed 2026-06-11 | |
| 2026-01-31 | $4.09M 10-Q · filed 2026-03-16 | |
| 2025-10-31 | $4.00M 10-Q · filed 2025-12-12 | |
| 2025-07-31 | $3.98M 10-Q · filed 2026-06-11 | |
| 2025-04-30 | $3.94M 10-Q · filed 2025-06-11 | |
| 2025-01-31 | $3.18M 10-Q · filed 2025-03-14 | |
| 2024-10-31 | $3.87M 10-Q · filed 2024-12-11 | |
| 2024-07-31 | $4.07M 10-K · filed 2025-10-29 | |
| 2024-04-30 | $4.46M 10-Q · filed 2024-06-14 | |
| 2024-01-31 | -$2.69M 10-Q · filed 2024-03-14 | |
| 2023-10-31 | -$3.69M 10-Q · filed 2023-12-14 | |
| 2023-07-31 | -$3.66M 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | -$3.64M 10-Q · filed 2023-06-13 | |
| 2023-01-31 | -$3.57M 10-Q · filed 2023-03-14 | |
| 2022-10-31 | -$3.41M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | -$3.31M 10-K · filed 2023-10-30 | |
| 2022-04-30 | -$3.24M 10-Q · filed 2022-06-14 | |
| 2022-01-31 | -$3.22M 10-Q · filed 2022-03-17 | |
| 2021-10-31 | -$2.97M 10-Q/A · filed 2022-02-28 | $14.33M 10-Q · filed 2021-12-15 |
| 2021-07-31 | $14.42M 10-K · filed 2022-10-31 | |
| 2021-04-30 | $14.49M 10-Q · filed 2021-06-14 | |
| 2021-01-31 | $14.58M 10-Q · filed 2021-03-17 | |
| 2020-10-31 | $13.74M 10-Q · filed 2020-12-15 | |
| 2020-07-31 | $13.73M 10-K · filed 2021-10-18 | |
| 2020-04-30 | $13.77M 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $13.85M 10-Q · filed 2020-03-05 | |
| 2019-10-31 | $13.81M 10-Q · filed 2019-12-09 | |
| 2019-07-31 | $13.78M 10-K · filed 2020-10-29 | |
| 2019-04-30 | $8.86M 10-Q · filed 2019-06-05 | |
| 2019-01-31 | $9.01M 10-Q · filed 2019-03-12 | |
| 2018-10-31 | $8.68M 10-Q · filed 2018-12-10 | |
| 2018-07-31 | $8.87M 10-K · filed 2019-10-04 | |
| 2018-04-30 | $9.51M 10-Q · filed 2018-06-11 | |
| 2018-01-31 | $9.68M 10-Q · filed 2018-03-12 | |
| 2017-07-31 | $9.34M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |